Reports


United States Generic Drugs Market and Forecast 2020-2026

  • TBI167707
  • October 07, 2020
  • United States of America
  • 132 pages
  • IFF Market Research
                                              A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.

The United States average gross margin of generic drugs is in the decreasing trend, from 45.19% in 2011 to 43.56% in 2015. With the situation of global economy, gross margin will be in decreasing trend in the following five years.

Market Analysis and Insights: Global Generic Drugs Market

This report focuses on Global Generic Drugs market.
The United States Generic Drugs market size is projected to reach US$ 505220 million by 2026, from US$ 285180 million in 2020, at a CAGR of 10.0% during 2021-2026.

United States Generic Drugs Scope and Market Size

Generic Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Generic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Generic Drugs market is segmented into
  • Simple Generic Drugs
  • Super Generic Drugs
  • Biosimilars
Segment by Application, the Generic Drugs market is segmented into
  • CNS
  • Cardiovascular
  • Genitourinary/Hormonal Drugs
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
  • Others
Regional and Country-level Analysis The Generic Drugs market is analysed and market size information is provided by regions (countries). The key regions covered in the Generic Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026. Competitive Landscape and Generic Drugs Market Share Analysis Generic Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Generic Drugs business, the date to enter into the Generic Drugs market, Generic Drugs product introduction, recent developments, etc. The major vendors covered:
  • Teva
  • Novartis - Sandoz
  • Mylan
  • Sun Pharmaceutical
  • Aspen
  • Fresenius Kabi
  • Pfizer (Hospira)
  • Sanofi
  • Aurobindo
  • Lupin
  • Dr. Reddys
  • Apotex
  • Cipla
  • ENDO (Par Pharmaceutical)
  • Stada Arzneimittel
  • Krka Group
  • Nichi-Iko Pharmaceutical
  • Bausch Health
  • Zydus Cadila
  • Hikma

Table of Contents

Chapter 1. Preface
	
		1.1. Report Description
		
			1.1.1. Objective
			1.1.2. Target Audience
			1.1.3. Unique Selling Proposition (USP) & Offerings
		
		
		1.2. Research Scope
		1.3. Research Methodology
		
			1.3.1. Market Research Process
			1.3.2. Market Research Methodology
			1.3.3. Level 1: Primary Research
			1.3.4. Level 2: Secondary Research
			1.3.5. Level 3: Data Validation and Expert Panel Assessment Report Description and Scope
			
Chapter 2. Executive Summary
	
		2.1. Global United States Generic Drugs 2019-2029 (USD Billion)
		2.2. Global United States Generic Drugs: Market Snapshot
	 
Chapter 3. Global United States Generic Drugs - Industry Analysis
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form

 

Related Reports